Jazz Pharmaceuticals (JAZZ)
250.41
-3.81 (1.50%)
Upcoming Events
Latest Headlines
Raymond James sees potential for beats across biopharma coverage
July 21, 2026 6:12 AM - StreetInsider
Jazz Pharmaceuticals to Report Second Quarter Financial Results on August 3, 2026
July 20, 2026 4:15 PM - PR NewsWire
Canaccord Starts Jazz Pharmaceuticals (JAZZ) at Buy
July 16, 2026 4:07 PM - StreetInsider
Form DEFA14A Jazz Pharmaceuticals
July 14, 2026 4:36 PM - SEC Filing
Jazz Pharmaceuticals (JAZZ) PT Raised to $285 at Wells Fargo
July 14, 2026 6:25 AM - StreetInsider
Jazz Pharmaceuticals (JAZZ) PT Raised to $260 at Barclays
July 14, 2026 5:12 AM - StreetInsider
Jazz Pharmaceuticals (JAZZ) PT Lowered to $254 at Truist Securities
July 7, 2026 7:09 AM - StreetInsider
Form 4 Jazz Pharmaceuticals For: Jul 01 Filed by: COZADD BRUCE C
July 6, 2026 6:23 PM - SEC Filing
Form 4 Jazz Pharmaceuticals For: Jun 30 Filed by: Pearce Samantha
July 2, 2026 6:28 PM - SEC Filing
Form 4 Jazz Pharmaceuticals For: Jun 30 Filed by: GALA RENEE D
July 2, 2026 6:22 PM - SEC Filing
Form 4 Jazz Pharmaceuticals For: Jun 30 Filed by: Iannone Robert
July 2, 2026 6:17 PM - SEC Filing
Form 4 Jazz Pharmaceuticals For: Jun 30 Filed by: Patil Neena M
July 2, 2026 6:10 PM - SEC Filing
Form 4 Jazz Pharmaceuticals For: Jun 30 Filed by: Johnson Philip L
July 2, 2026 6:05 PM - SEC Filing
Form 144 Jazz Pharmaceuticals Filed by: COZADD BRUCE C
July 1, 2026 3:55 PM - SEC Filing
Form 4 Jazz Pharmaceuticals For: Jun 15 Filed by: Smith Mark Douglas
June 17, 2026 4:45 PM - SEC Filing
Jazz Pharmaceuticals and AbCellera ink antibody research deal
June 17, 2026 7:01 AM - StreetInsider
Jazz Pharmaceuticals and AbCellera Announce Collaboration to Discover Next-Generation T-cell Engaging Multispecific Antibodies
June 17, 2026 7:00 AM - BizWire
Jazz Pharmaceuticals presents Xywav sleep disorder data at SLEEP 2026 conference
June 16, 2026 4:06 PM - StreetInsider
Jazz Pharmaceuticals Delivers Extensive Late-Breaking Data at SLEEP 2026, Demonstrating Real-World Impact of Xywav® (calcium, magnesium, potassium, and sodium oxybates) on Patient Outcomes Across Nar
June 16, 2026 4:05 PM - PR NewsWire
Form 144 Jazz Pharmaceuticals Filed by: Smith Mark Douglas
June 15, 2026 4:09 PM - SEC Filing
Form 4 Jazz Pharmaceuticals For: Jun 10 Filed by: Patil Neena M
June 12, 2026 4:15 PM - SEC Filing
Jazz's Zepzelca fails late-stage lung cancer trial
June 12, 2026 8:01 AM - StreetInsider
Jazz Pharmaceuticals Provides Update on Zepzelca® (lurbinectedin) Phase 3 LAGOON Trial in Second-Line Small Cell Lung Cancer
June 12, 2026 8:00 AM - PR NewsWire
Form 144 Jazz Pharmaceuticals Filed by: Patil Neena M
June 10, 2026 4:05 PM - SEC Filing
Jazz Pharmaceuticals (JAZZ) PT Raised to $307 at BofA Securities
June 10, 2026 5:22 AM - StreetInsider
Bernstein SocGen Reiterates Market Perform Rating on Jazz Pharmaceuticals (JAZZ)
June 9, 2026 9:27 AM - StreetInsider
Truist Securities Assumes Jazz Pharmaceuticals (JAZZ) at Buy
June 9, 2026 6:06 AM - StreetInsider
Form ARS Jazz Pharmaceuticals For: Dec 31
June 8, 2026 4:10 PM - SEC Filing
Form DEFA14A Jazz Pharmaceuticals
June 8, 2026 4:07 PM - SEC Filing
Form DEF 14A Jazz Pharmaceuticals For: Jul 23
June 8, 2026 4:06 PM - SEC Filing
Form 4 Jazz Pharmaceuticals For: Jun 03 Filed by: GALA RENEE D
June 5, 2026 4:41 PM - SEC Filing
Jazz Pharmaceuticals to present 21 abstracts at SLEEP 2026 conference
June 4, 2026 7:45 AM - StreetInsider
Jazz Pharmaceuticals to Present Comprehensive Data at SLEEP 2026 Highlighting Broad Treatment Effects of Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution for People with Narc
June 4, 2026 7:45 AM - PR NewsWire
Form 4 Jazz Pharmaceuticals For: Jun 01 Filed by: COZADD BRUCE C
June 3, 2026 5:10 PM - SEC Filing
Form 144 Jazz Pharmaceuticals Filed by: COZADD BRUCE C
June 1, 2026 4:14 PM - SEC Filing
Form 4 Jazz Pharmaceuticals For: May 28 Filed by: Patil Neena M
June 1, 2026 4:10 PM - SEC Filing
Form 4 Jazz Pharmaceuticals For: May 28 Filed by: Pearce Samantha
June 1, 2026 4:08 PM - SEC Filing
Form 4 Jazz Pharmaceuticals For: May 28 Filed by: Mulligan Seamus
June 1, 2026 4:03 PM - SEC Filing
Form PRE 14A Jazz Pharmaceuticals For: Jul 23
May 29, 2026 4:12 PM - SEC Filing
Form 8-K Jazz Pharmaceuticals For: May 25
May 29, 2026 4:05 PM - SEC Filing
Form 144 Jazz Pharmaceuticals Filed by: Patil Neena M
May 28, 2026 5:09 PM - SEC Filing
Form 144 Jazz Pharmaceuticals Filed by: Pearce Samantha
May 28, 2026 5:04 PM - SEC Filing
JPMorgan says large-cap biotech is back as profits and pipelines fuel upside
May 28, 2026 4:07 PM - StreetInsider
Form 4 Jazz Pharmaceuticals For: May 22 Filed by: Winningham Rick E
May 27, 2026 6:13 PM - SEC Filing
Form 4 Jazz Pharmaceuticals For: May 22 Filed by: McSharry Heather Ann
May 27, 2026 6:07 PM - SEC Filing
Jazz Pharmaceuticals publishes cancer trial results in medical journal
May 27, 2026 5:00 PM - StreetInsider
Phase 3 HERIZON-GEA-01 Results Published in The New England Journal of Medicine Show Durable and Consistent Survival Benefit with Ziihera® (zanidatamab-hrii) Combinations in First-Line HER2+ Locally
May 27, 2026 5:00 PM - PR NewsWire
Jazz Pharmaceuticals (JAZZ) PT Raised to $253 at Barclays
May 27, 2026 2:26 AM - StreetInsider
Form 144 Jazz Pharmaceuticals Filed by: McSharry Heather Ann
May 22, 2026 4:27 PM - SEC Filing
Form 144 Jazz Pharmaceuticals Filed by: Winningham Rick E
May 22, 2026 4:13 PM - SEC Filing
Jazz Pharmaceuticals (JAZZ) PT Raised to $301 at Piper Sandler
May 22, 2026 7:32 AM - StreetInsider
Bernstein SocGen Group Starts Jazz Pharmaceuticals (JAZZ) at Market Perform
May 21, 2026 4:24 PM - StreetInsider
JPMorgan sees biotech sector at inflection point, resumes coverage on 14 Firms
May 20, 2026 3:10 PM - StreetInsider
JPMorgan Reinstates Jazz Pharmaceuticals (JAZZ) at Overweight
May 20, 2026 4:30 AM - StreetInsider
UBS Upgrades Jazz Pharmaceuticals (JAZZ) to Buy
May 19, 2026 4:14 AM - StreetInsider
Jazz Pharmaceuticals to Participate in Upcoming Investor Conferences
May 12, 2026 4:15 PM - PR NewsWire
Jazz Pharmaceuticals (JAZZ) PT Raised to $245 at Morgan Stanley
May 7, 2026 9:01 AM - StreetInsider
Jazz Pharmaceuticals (JAZZ) PT Raised to $265 at Wells Fargo
May 6, 2026 8:46 AM - StreetInsider
Jazz Pharmaceuticals (JAZZ) PT Raised to $275 at TD Cowen
May 6, 2026 8:18 AM - StreetInsider
Jazz Pharmaceuticals (JAZZ) PT Raised to $234 at Barclays
May 6, 2026 7:03 AM - StreetInsider
Jazz Pharmaceuticals (JAZZ) PT Raised to $252 at Baird
May 6, 2026 6:43 AM - StreetInsider
Jazz Pharmaceuticals (JAZZ) PT Raised to $258 at RBC Capital
May 6, 2026 5:24 AM - StreetInsider
Jazz Pharmaceuticals (JAZZ) Tops Q1 EPS by 172c; offers guidance
May 5, 2026 4:31 PM - StreetInsider
Form 4 Jazz Pharmaceuticals For: May 01 Filed by: COZADD BRUCE C
May 5, 2026 4:27 PM - SEC Filing
Form 10-Q Jazz Pharmaceuticals For: Mar 31
May 5, 2026 4:10 PM - SEC Filing
Form 8-K Jazz Pharmaceuticals For: May 05
May 5, 2026 4:08 PM - SEC Filing
Jazz Pharmaceuticals Announces First Quarter 2026 Financial Results
May 5, 2026 4:05 PM - PR NewsWire
Form 144 Jazz Pharmaceuticals Filed by: COZADD BRUCE C
May 1, 2026 3:45 PM - SEC Filing
Jazz Pharmaceuticals (JAZZ) PT Raised to $232 at Jefferies
April 30, 2026 1:31 PM - StreetInsider
Form SCHEDULE 13G Jazz Pharmaceuticals Filed by: VANGUARD CAPITAL MANAGEMENT LLC
April 30, 2026 11:19 AM - SEC Filing
FDA accepts Jazz Pharmaceuticals filing for cancer drug combination
April 27, 2026 7:45 AM - StreetInsider
Jazz Pharmaceuticals Announces FDA Acceptance and Priority Review of Supplemental Biologics License Application for Ziihera® (zanidatamab-hrii) Combinations in First-Line HER2+ Locally Advanced or Me
April 27, 2026 7:45 AM - PR NewsWire
Form 10-K/A Jazz Pharmaceuticals For: Dec 31
April 24, 2026 4:10 PM - SEC Filing
Jazz Pharmaceuticals (JAZZ) PT Raised to $255 at Needham
April 24, 2026 8:44 AM - StreetInsider
Full Article List
